TY - JOUR
T1 - Microbial tryptophan metabolites modulate blood-brain and gut barriers in vitro
AU - Rosell-Cardona, Cristina
AU - Knox, Emily G.
AU - Sánchez-Díaz, Paula
AU - Leigh, Sarah Jane
AU - Tirelli, Emanuela
AU - Goodson, Michael S.
AU - Kelley-Loughnane, Nancy
AU - Aburto, María R.
AU - Kittel-Schneider, Sarah
AU - Cryan, John F.
AU - Clarke, Gerard
N1 - Publisher Copyright:
© 2025 The Author(s). Published by Elsevier B.V. on behalf of European College of Neuropsychopharmacology. This is an open access article under the CC BY license. http://creativecommons.org/licenses/by/4.0/
PY - 2026/1/1
Y1 - 2026/1/1
N2 - The gut microbiota influences brain function via the gut-brain axis, but the underlying molecular processes remain unclear. Critical to this communication are barrier systems, such as the epithelial gut and the blood-brain barrier, which mediate the interface between circulating signals and gut-brain communication. Microbial metabolites are key mediators of the gut microbiota that can influence barrier integrity. In this study, we used well-established in vitro models of the blood-brain and gut barriers and exposed them to a wide range of physiologically relevant stress-associated microbial metabolites, including tryptophan-derived metabolites with and without lipopolysaccharide (LPS) as a disrupting insult. We demonstrated that indole, indole-3-acetate, indole-3-propionate and tryptamine can modulate both gut and brain barriers in a dose- and cell-type dependent manner. Our findings suggest that specific indole metabolites should be further evaluated as promising novel therapeutic interventions to regulate barrier integrity along the microbiota-gut-brain axis.
AB - The gut microbiota influences brain function via the gut-brain axis, but the underlying molecular processes remain unclear. Critical to this communication are barrier systems, such as the epithelial gut and the blood-brain barrier, which mediate the interface between circulating signals and gut-brain communication. Microbial metabolites are key mediators of the gut microbiota that can influence barrier integrity. In this study, we used well-established in vitro models of the blood-brain and gut barriers and exposed them to a wide range of physiologically relevant stress-associated microbial metabolites, including tryptophan-derived metabolites with and without lipopolysaccharide (LPS) as a disrupting insult. We demonstrated that indole, indole-3-acetate, indole-3-propionate and tryptamine can modulate both gut and brain barriers in a dose- and cell-type dependent manner. Our findings suggest that specific indole metabolites should be further evaluated as promising novel therapeutic interventions to regulate barrier integrity along the microbiota-gut-brain axis.
UR - https://www.scopus.com/pages/publications/105023393170
U2 - 10.1016/j.nsa.2025.106876
DO - 10.1016/j.nsa.2025.106876
M3 - Article
AN - SCOPUS:105023393170
SN - 2772-4085
VL - 5
JO - Neuroscience Applied
JF - Neuroscience Applied
M1 - 106876
ER -